1. Home
  2. BCBP vs SPRO Comparison

BCBP vs SPRO Comparison

Compare BCBP & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$9.96

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
SPRO
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
156.3M
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
BCBP
SPRO
Price
$9.96
$1.19
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
123.7K
2.1M
Earning Date
04-21-2026
05-13-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
111.81
EPS
0.26
N/A
Revenue
N/A
$66,802,000.00
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
$300.00
P/E Ratio
$39.27
N/A
Revenue Growth
N/A
39.24
52 Week Low
$7.31
$1.08
52 Week High
$11.71
$3.08

Technical Indicators

Market Signals
Indicator
BCBP
SPRO
Relative Strength Index (RSI) 46.39 21.32
Support Level $9.74 $1.08
Resistance Level $10.60 $2.42
Average True Range (ATR) 0.28 0.15
MACD 0.01 -0.01
Stochastic Oscillator 31.64 7.14

Price Performance

Historical Comparison
BCBP
SPRO

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: